EP0530216A4 - Administration of monoclonal antibodies against respiratory viruses - Google Patents

Administration of monoclonal antibodies against respiratory viruses

Info

Publication number
EP0530216A4
EP0530216A4 EP19910908428 EP91908428A EP0530216A4 EP 0530216 A4 EP0530216 A4 EP 0530216A4 EP 19910908428 EP19910908428 EP 19910908428 EP 91908428 A EP91908428 A EP 91908428A EP 0530216 A4 EP0530216 A4 EP 0530216A4
Authority
EP
European Patent Office
Prior art keywords
administration
monoclonal antibodies
antibodies against
respiratory viruses
against respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910908428
Other versions
EP0530216A1 (en
Inventor
James F. Young
Gregory A. Prince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
MedImmune LLC
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC, Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical MedImmune LLC
Publication of EP0530216A1 publication Critical patent/EP0530216A1/en
Publication of EP0530216A4 publication Critical patent/EP0530216A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19910908428 1990-04-19 1991-04-18 Administration of monoclonal antibodies against respiratory viruses Withdrawn EP0530216A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52292290A 1990-04-19 1990-04-19
US522922 1990-04-19

Publications (2)

Publication Number Publication Date
EP0530216A1 EP0530216A1 (en) 1993-03-10
EP0530216A4 true EP0530216A4 (en) 1993-06-30

Family

ID=24082929

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910908428 Withdrawn EP0530216A4 (en) 1990-04-19 1991-04-18 Administration of monoclonal antibodies against respiratory viruses

Country Status (2)

Country Link
EP (1) EP0530216A4 (en)
WO (1) WO1991016074A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539522B1 (en) * 1990-07-19 1998-12-30 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
US5762905A (en) * 1992-09-16 1998-06-09 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
US6685942B1 (en) 1993-12-10 2004-02-03 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
EP0724602A4 (en) * 1993-07-30 1998-12-23 Oravax Inc MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS
WO2004010935A2 (en) * 2002-07-25 2004-02-05 Medimmune, Inc. Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
AU2004203727C1 (en) 2003-01-07 2008-08-21 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
JP2008546805A (en) * 2005-06-23 2008-12-25 メディミューン，エルエルシー Antibody formulations with optimal aggregation and fragmentation profiles
PL2152872T3 (en) 2007-05-25 2011-03-31 Symphogen As Method for manufacturing a recombinant polyclonal protein
CN105992772A (en) 2014-02-10 2016-10-05 Igm生命科学股份有限公司 IgA multi-specific binding molecules

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001473A1 (en) * 1990-07-19 1992-02-06 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Improved immunotherapeutic method of preventing or treating viral respiratory tract disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625015A (en) * 1982-08-23 1986-11-25 Scripps Clinic & Research Foundation Broad spectrum influenza antisera
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
FR2590674B1 (en) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med NEW DIAGNOSTIC REAGENTS
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001473A1 (en) * 1990-07-19 1992-02-06 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Improved immunotherapeutic method of preventing or treating viral respiratory tract disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF VIROLOGY vol. 63, no. 7, July 1989, BALTIMORE pages 2941 - 2950 BEELER, J.A. ET AL 'Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function' *
See also references of WO9116074A1 *
VACCINES 91 vol. 91, 1991, NEW YORK pages 283 - 288 BANSAL, G.P. ET AL 'Efficacy of passively administered monoclonal antibodies against respiratory syncytial virus infection in cotton rats' Modern approaches to new vaccines including prevention of aids;eighth annual meeting, cold spring harbor, new york, USA, september 1990. *

Also Published As

Publication number Publication date
WO1991016074A1 (en) 1991-10-31
EP0530216A1 (en) 1993-03-10

Similar Documents

Publication Publication Date Title
IL99363A0 (en) Pharmaceutical compositions comprising homoconjugated monoclonal antibodies
CS285491A3 (en) Nasal pharmaceutical
PL289264A1 (en) Inhaler
GB9015077D0 (en) Inhaler
GB9023281D0 (en) Inhaler
IL88145A0 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
EP0652770A4 (en) Oral administration of antigens.
EP0528951A4 (en) Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
NO914636L (en) powder inhaler
DE3482905D1 (en) MONOCLONAL ANTIBODIES AGAINST LUNG CANCER OF THE "NON-SMALL-CELL" TYPE.
HUT58371A (en) Recombinant virus of marek-disease
IL97005A0 (en) Recombinant human anti-cd18 antibodies
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
DE69331635T2 (en) powder inhaler
EP0530216A4 (en) Administration of monoclonal antibodies against respiratory viruses
EP0711310A4 (en) Human antibodies against varicella-zoster virus
DK49791D0 (en) NASAL POWDER PREPARATION
GB9027255D0 (en) Closure system for inhalers
ZA919373B (en) Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and blends thereof
EP0506523A3 (en) Monoclonal antibodies
IL97288A0 (en) Photosensitive formulations containing carbodiimide derivatives and processes for the preparation thereof
EP0485749A3 (en) Chemical modification of antibodies for creating of immunoconjugates
GB9102616D0 (en) Antibodies and their use as drug vectors
AU3432389A (en) Human monoclonal antibodies against rabies virus
GB9223676D0 (en) Modified antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19921002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930511

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19930930

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000126